Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 2956 for cancer

Edit search filters
  1. Consent Forms in Cancer Research: Examining the Effect of Length on Readability

    Rochester, MN

  2. Electronic Patient Reporting of Symptoms During Cancer Treatment

    La Crosse, WI, Eau Claire, WI, Mankato, MN

  3. Virtual Dignity Therapy for Palliative Care Patients with Advanced Cancer

    Rochester, MN

  4. Testing for Spread of Stomach Cancer to Abdominal Cavity

    Rochester, MN

  5. Engineering Gut Microbiome to Target Breast Cancer

    Jacksonville, FL

  6. A Study to Compare Mobile Health and Social Media Physical Activity Intervention Among Adolescent and Young Adult Childhood Cancer Survivors

    Rochester, MN

  7. Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Advanced Cancer Patients

    Rochester, MN, Mankato, MN

  8. Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients

    Albert Lea, MN, Eau Claire, WI, Rochester, MN

  9. A Study to Evaluate Non-Operative Management and Early Response Assessment in Rectal Cancer

    Rochester, MN

  10. Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer